Sandro Belvedere
Corporate Officer/Principal bei ARMGO Pharma, Inc.
Profil
Sandro Belvedere's current job is Vice President-Chemistry at ARMGO Pharma, Inc. He previously worked as a Research Leader & Senior Scientist at GSK Plc and as a Research Scientist at Aton Pharma, Inc. He holds a graduate degree from the University of Rochester, an undergraduate degree from The American University of Rome, and a doctorate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Sandro Belvedere
| Unternehmen | Position | Beginn |
|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2006 |
Ehemalige bekannte Positionen von Sandro Belvedere
| Unternehmen | Position | Ende |
|---|---|---|
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Ausbildung von Sandro Belvedere
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Rochester Christian University | Graduate Degree |
| The American University of Rome | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
